James F. Oliviero III - 01 Jan 2022 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Signature
/s/ James F. Oliviero, III
Issuer symbol
CKPT
Transactions as of
01 Jan 2022
Transactions value $
-$1,909,802
Form type
4
Filing time
22 Apr 2022, 20:31:04 UTC
Next filing
02 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Tax liability -$942K -303K -8.39% $3.11 3.31M 01 Jan 2022 Direct F1, F2
transaction CKPT COMMON STOCK Tax liability -$147K -53K -1.6% $2.77 3.25M 06 Jan 2022 Direct F1, F2
transaction CKPT COMMON STOCK Tax liability -$313K -143K -4.4% $2.19 3.11M 24 Jan 2022 Direct F1, F2
transaction CKPT COMMON STOCK Tax liability -$78.7K -32K -1.03% $2.46 3.08M 30 Jan 2022 Direct F1, F2
transaction CKPT COMMON STOCK Tax liability -$218K -118K -3.82% $1.85 2.96M 24 Feb 2022 Direct F1, F2
transaction CKPT COMMON STOCK Sale -$155K -86.4K -2.92% $1.79 2.87M 04 Apr 2022 Direct F2, F3
transaction CKPT COMMON STOCK Sale -$24.8K -14K -0.49% $1.77 2.86M 05 Apr 2022 Direct F2, F4
transaction CKPT COMMON STOCK Sale -$32.1K -21.3K -0.74% $1.51 2.84M 13 Apr 2022 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer.
F2 Includes shares of restricted Common Stock, which vest over various time periods.
F3 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.